Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping
暂无分享,去创建一个
M. Säemann | J. Mascherbauer | M. Antlanger | D. Bonderman | S. Aschauer | F. Duca | A. Kammerlander
[1] anonymous,et al. Comprehensive review , 2019 .
[2] G. Hindricks,et al. CMR-Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis: The Importance of Coexisting Myocardial Inflammation. , 2017, JACC. Cardiovascular imaging.
[3] S. Raman,et al. Global myocardial oedema in advanced decompensated heart failure , 2017, European heart journal cardiovascular Imaging.
[4] Matthias Schneider,et al. Diameter of the Pulmonary Artery in Relation to the Ascending Aorta: Association with Cardiovascular Outcome. , 2017, Radiology.
[5] Yuedong Wang,et al. Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort. , 2017, Kidney international.
[6] M. Säemann,et al. Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis , 2017, Kidney and Blood Pressure Research.
[7] Susan Francis,et al. Intradialytic Cardiac Magnetic Resonance Imaging to Assess Cardiovascular Responses in a Short-Term Trial of Hemodiafiltration and Hemodialysis. , 2017, Journal of the American Society of Nephrology : JASN.
[8] M. Säemann,et al. Fluid status and outcome in patients with heart failure and preserved ejection fraction. , 2017, International journal of cardiology.
[9] Héctor Bueno,et al. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica , 2016 .
[10] S. Plein,et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review , 2016, Journal of Cardiovascular Magnetic Resonance.
[11] E. Keeley,et al. Obesity paradox in heart failure: a heavy matter , 2016, ESC heart failure.
[12] P. Ponikowski,et al. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.
[13] D. Stensel,et al. Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients. , 2016, Kidney international.
[14] A. Radjenovic,et al. Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping , 2016, Kidney international.
[15] B. Mullan,et al. Volume Overload Profiles in Patients With Preserved and Reduced Ejection Fraction Chronic Heart Failure: Are There Differences? A Pilot Study. , 2016, JACC. Heart failure.
[16] Matthias Gutberlet,et al. Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. , 2016, Journal of the American College of Cardiology.
[17] M. Worthley,et al. The Impact of Arteriovenous Fistulae for Hemodialysis on the Cardiovascular System , 2016, Seminars in dialysis.
[18] Michael Jerosch-Herold,et al. T1 Mapping: Basic Techniques and Clinical Applications. , 2016, JACC. Cardiovascular imaging.
[19] A. Greiser,et al. T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication. , 2016, JACC. Cardiovascular imaging.
[20] S. Pfaffenberger,et al. Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction , 2015, Journal of Cardiovascular Magnetic Resonance.
[21] D. Tarng,et al. Volume Overload and Adverse Outcomes in Chronic Kidney Disease: Clinical Observational and Animal Studies , 2015, Journal of the American Heart Association.
[22] W. Hörl,et al. Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status , 2013, BMC Nephrology.
[23] C. Kramer,et al. Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping , 2013, Journal of magnetic resonance imaging : JMRI.
[24] G. Maurer,et al. Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction , 2013, Circulation. Cardiovascular imaging.
[25] Helmut Baumgartner,et al. Size Matters! Impact of Age, Sex, Height, and Weight on the Normal Heart Size , 2013, Circulation. Cardiovascular imaging.
[26] C. Lam,et al. Heart failure with preserved or reduced ejection fraction in patients treated with peritoneal dialysis. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] Reza Razavi,et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[28] A. Go,et al. Associations between kidney function and subclinical cardiac abnormalities in CKD. , 2012, Journal of the American Society of Nephrology : JASN.
[29] M. Robson,et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.
[30] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.
[31] R. Fluck,et al. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[32] P. Klemmer,et al. High‐output heart failure secondary to arteriovenous fistula , 2011, Hemodialysis international. International Symposium on Home Hemodialysis.
[33] M. Hayward,et al. Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.
[34] J. Passauer,et al. Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: a cross-sectional study. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] K. Musallam,et al. High-output cardiac failure secondary to a large arteriovenous fistula: a persistent threat to the dialysis and kidney transplant patient , 2009, NDT plus.
[36] D. Marcelli,et al. The mortality risk of overhydration in haemodialysis patients , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[37] P. Wabel,et al. Importance of Whole-Body Bioimpedance Spectroscopy for the Management of Fluid Balance , 2009, Blood Purification.
[38] Pedagógia,et al. Cross Sectional Study , 2019 .
[39] A. Bosy-Westphal,et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. , 2007, The American journal of clinical nutrition.
[40] R. Jofré,et al. Inflammatory syndrome in patients on hemodialysis. , 2006, Journal of the American Society of Nephrology : JASN.
[41] G. Filippatos,et al. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. , 2006, The American journal of medicine.
[42] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.
[43] Allen R Nissenson,et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. , 2003, The American journal of medicine.
[44] K. Kalantar-Zadeh,et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. , 2003, Kidney international.
[45] T. Inenaga,et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.